Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 8, 2013, Pages 1346-1362

  Ho, Nancy ^a   Sommers, Marilyn S ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cognition; Depression; Diabetes; Hippocampus; Neurogenesis; Neuroplasticity

Indexed keywords

ALDOSTERONE; AMINOGUANIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; CORTICOSTERONE; DOPAMINE; ENALAPRIL; ESTROGEN; EXENDIN 4; FLUOXETINE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOCORTICOID RECEPTOR; GLUCOSE TRANSPORTER; HYDROCORTISONE; INSULIN; LEPTIN RECEPTOR; LIRAGLUTIDE; MIFEPRISTONE; NEUROTROPHIN; NIMODIPINE; PROTEIN SERINE THREONINE KINASE; SEROTONIN; SOMATOMEDIN; STREPTOZOCIN; STRESS HORMONE; SUCROSE;

ADRENALECTOMY; AGING; ANHEDONIA; APOPTOSIS; BEHAVIOR; CELL PROLIFERATION; CELL SURVIVAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CORTICOSTERONE BLOOD LEVEL; DEMENTIA; DEPRESSION; DIABETES MELLITUS; ENVIRONMENTAL ENRICHMENT; EXERCISE; GENE MUTATION; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; GOTO KAKIZAKI RAT; HIPPOCAMPUS; HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPID DIET; LOCOMOTION; LONG TERM POTENTIATION; LOW DRUG DOSE; MEMORY; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; RNA SPLICING; SPATIAL LEARNING; STREPTOZOCIN DIABETES; SUGAR INTAKE; WEIGHT GAIN;

COGNITION; DEPRESSION; DIABETES; HIPPOCAMPUS; NEUROGENESIS; NEUROPLASTICITY;

BRAIN; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HIPPOCAMPUS; HUMANS; NEUROGENESIS;

EID: 84879705689     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.03.010     Document Type: Review

References (159)

1. ADA American Diabetes Association Diabetes Statistics 2011.
2. Adili F., Larijani B., Haghighatpanah M. Diabetic patients: psychological aspects. Ann. N. Y. Acad. Sci. 2006, 1084:329-349.
3. Airan R.D., Meltzer L.A., Roy M., Gong Y., Chen H., Deisseroth K. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 2007, 317:819-823.
4. Allen T.J., Cooper M.E., Lan H.Y. Use of genetic mouse models in the study of diabetic nephropathy. Curr. Diab. Rep. 2004, 4:435-440.
5. Alvarez E.O., Beauquis J., Revsin Y., Banzan A.M., Roig P., De Nicola A.F., Saravia F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav. Brain Res. 2009, 198:224-230.
6. Alzoubi K.H., Aleisa A.M., Alkadhi K.A. Impairment of long-term potentiation in the CA1, but not dentate gyrus, of the hippocampus in Obese Zucker rats: role of calcineurin and phosphorylated CaMKII. J. Mol. Neurosci.: MN 2005, 27:337-346.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Washington, DC 2000, revised 4th ed.
8. Antunes M., Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn. Process. 2012, 13:93-110.
9. Artola A., Kamal A., Ramakers G.M., Gardoni F., Di Luca M., Biessels G.J., Cattabeni F., Gispen W.H. Synaptic plasticity in the diabetic brain: advanced aging?. Prog. Brain Res. 2002, 138:305-314.
10. Astle F. Diabetes and depression: a review of the literature. Nurs. Clin. N. Am. 2007, 42:67-78. vii.
11. Balu D.T., Hodes G.E., Hill T.E., Ho N., Rahman Z., Bender C.N., Ring R.H., Dwyer J.M., Rosenzweig-Lipson S., Hughes Z.A., Schechter L.E., Lucki I. Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. J. Pharmacol. Toxicol. Methods 2009, 59:100-107.
12. Balu D.T., Lucki I. Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci. Biobehav. Rev. 2009, 33:232-252.
13. Baquer N.Z., Taha A., Kumar P., McLean P., Cowsik S.M., Kale R.K., Singh R., Sharma D. A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 2009, 10:377-413.
14. Beauquis J., Homo-Delarche F., Giroix M.H., Ehses J., Coulaud J., Roig P., Portha B., De Nicola A.F., Saravia F. Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats. Exp. Neurol. 2010, 222:125-134.
15. Beauquis J., Roig P., De Nicola A.F., Saravia F. Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PloS one 2010, 5:e13993.
16. Beauquis J., Roig P., Homo-Delarche F., De Nicola A., Saravia F. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur. J. Neurosci. 2006, 23:1539-1546.
17. Beauquis J., Saravia F., Coulaud J., Roig P., Dardenne M., Homo-Delarche F., De Nicola A. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Exp. Neurol. 2008, 210:359-367.
18. Bekinschtein P., Oomen C.A., Saksida L.M., Bussey T.J. Effects of environmental enrichment and voluntary exercise on neurogenesis, learning and memory, and pattern separation: BDNF as a critical variable?. Semin. Cell Dev. Biol. 2011, 22:536-542.
19. Belanger A., Lavoie N., Trudeau F., Massicotte G., Gagnon S. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats. Physiol. Behav. 2004, 83:483-494.
20. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
21. Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998, 800:125-135.
22. Biessels G.J., Kerssen A., de Haan E.H., Kappelle L.J. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diab. 2007, 1:187-193.
23. Biessels G.J., Koffeman A., Scheltens P. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J. Neurol. 2006, 253:477-482.
24. Biessels G.J., ter Laak M.P., Kamal A., Gispen W.H. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res. 2005, 1035:86-93.
25. Bilsland J.G., Haldon C., Goddard J., Oliver K., Murray F., Wheeldon A., Cumberbatch J., McAllister G., Munoz-Sanjuan I. A rapid method for the quantification of mouse hippocampal neurogenesis in vivo by flow cytometry. Validation with conventional and enhanced immunohistochemical methods. J. Neurosci. Methods 2006, 157:54-63.
26. Boitard C., Etchamendy N., Sauvant J., Aubert A., Tronel S., Marighetto A., Laye S., Ferreira G. Juvenile, but not adult exposure to high-fat diet impairs relational memory and hippocampal neurogenesis in mice. Hippocampus 2012.
27. Brismar T., Maurex L., Cooray G., Juntti-Berggren L., Lindstrom P., Ekberg K., Adner N., Andersson S. Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology 2007, 32:1041-1051.
28. Caldji C., Diorio J., Meaney M.J. Variations in maternal care in infancy regulate the development of stress reactivity. Biol. Psychiatry 2000, 48:1164-1174.
29. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol. 2010, 70:289-297.
30. Champaneri S., Wand G.S., Malhotra S.S., Casagrande S.S., Golden S.H. Biological basis of depression in adults with diabetes. Curr. Diab. Rep. 2010, 10:396-405.
31. Cheng S.T., Chow P.K., Song Y.Q., Yu E.C., Chan A.C., Lee T.M., Lam J.H. Mental and physical activities delay cognitive decline in older persons with dementia. Am. J. Geriatric Psychiatry 2013.
32. Clelland C.D., Choi M., Romberg C., Clemenson G.D., Fragniere A., Tyers P., Jessberger S., Saksida L.M., Barker R.A., Gage F.H., Bussey T.J. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 2009, 325:210-213.
33. Cosar M., Songur A., Sahin O., Uz E., Yilmaz R., Yagmurca M., Ozen O.A. The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr. Neurosci. 2008, 11:161-166.
34. Crews L., Adame A., Patrick C., Delaney A., Pham E., Rockenstein E., Hansen L., Masliah E. Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J. Neurosci. 2010, 30:12252-12262.
35. Crowley J.J., Lucki I. Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics. Curr. Pharm. Des. 2005, 11:157-169.
36. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29:547-569.
37. Czeh B., Lucassen P.J. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:250-260.
38. de Groot M., Doyle T., Kushnick M., Shubrook J., Merrill J., Rabideau E., Schwartz F. Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy. Curr. Diab. Rep. 2012, 12:157-166.
39. Dejgaard A., Gade A., Larsson H., Balle V., Parving A., Parving H.H. Evidence for diabetic encephalopathy. Diab. Med. 1991, 8:162-167.
40. Dere E., Huston J.P., De Souza Silva M.A. Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. Brain Res. Brain Res. Protoc. 2005, 16:10-19.
41. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 2006, 59:1136-1143.
42. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
43. Dudchenko P.A. An overview of the tasks used to test working memory in rodents. Neurosci. Biobehav. Rev. 2004, 28:699-709.
44. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
45. Eker C., Gonul A.S. Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research. World J. Biol. Psychiatry 2010, 11:19-35.
46. Elder G.A., De Gasperi R., Gama Sosa M.A. Research update: neurogenesis in adult brain and neuropsychiatric disorders. Mt. Sinai J. Med. 2006, 73:931-940.
47. Garcia-Segura L.M., Arevalo M.A., Azcoitia I. Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog. Brain Res. 2010, 181:251-272.
48. Gardoni F., Kamal A., Bellone C., Biessels G.J., Ramakers G.M., Cattabeni F., Gispent W.H., Di Luca M. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J. Neurochem. 2002, 80:438-447.
49. Gaudieri P.A., Chen R., Greer T.F., Holmes C.S. Cognitive function in children with type 1 diabetes: a meta-analysis. Diab. Care 2008, 31:1892-1897.
50. Gault V.A., Porter W.D., Flatt P.R., Holscher C. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int. J. Obes. (Lond.) 2010, 34:1341-1344.
51. Giarratana N., Penna G., Adorini L. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol. Biol. 2007, 380:285-311.
52. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50:711-719.
53. Goodman T., Trouche S., Massou I., Verret L., Zerwas M., Roullet P., Rampon C. Young hippocampal neurons are critical for recent and remote spatial memory in adult mice. Neuroscience 2010, 171:769-778.
54. Gowri P.M., Sengupta S., Bertera S., Katzenellenbogen B.S. Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility. Endocrinology 2007, 148:3685-3693.
55. Hamilton A., Patterson S., Porter D., Gault V.A., Holscher C. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J. Neurosci. Res. 2011, 89:481-489.
56. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
57. Hayes M.R. Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects. Physiol. Behav. 2012, 106:413-416.
58. Hershey T., Perantie D.C., Wu J., Weaver P.M., Black K.J., White N.H. Hippocampal volumes in youth with type 1 diabetes. Diabetes 2010, 59:236-241.
59. Ho N., Balu D.T., Hilario M.R., Blendy J.A., Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol. Behav. 2011, 105:702-708.
60. Hood K.K., Huestis S., Maher A., Butler D., Volkening L., Laffel L.M. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diab. Care 2006, 29:1389-1391.
61. Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005, 1037:204-208.
62. Huang G.J., Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol. Psychiatry 2006, 59:619-624.
63. Hwang I.K., Kim I.Y., Kim D.W., Yoo K.Y., Kim Y.N., Yi S.S., Won M.H., Lee I.S., Yoon Y.S., Seong J.K. Strain-specific differences in cell proliferation and differentiation in the dentate gyrus of C57BL/6N and C3H/HeN mice fed a high fat diet. Brain Res. 2008, 1241:1-6.
64. Iosifescu D.V. Treating depression in the medically ill. Psychiatr. Clin. North Am. 2007, 30:77-90.
65. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., Kunzel H.E., Pfennig A., Uhr M., Holsboer F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biol. Psychiatry 2007, 62:47-54.
66. Ismail K. Unraveling the pathogenesis of the depression-diabetes link. Depression and Diabetes 2010, 29-61. Wiley-Blackwell, West Susex, UK. W. Katon, M. Maj, N. Sartorius (Eds.).
67. Iwai T., Suzuki M., Kobayashi K., Mori K., Mogi Y., Oka J. The influences of juvenile diabetes on memory and hippocampal plasticity in rats: improving effects of glucagon-like peptide-1. Neurosci. Res. 2009, 64:67-74.
68. Izumi Y., Yamada K.A., Matsukawa M., Zorumski C.F. Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats. Diabetologia 2003, 46:1007-1012.
69. Jackson-Guilford J., Leander J.D., Nisenbaum L.K. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci. Lett. 2000, 293:91-94.
70. Jafari Anarkooli I., Sankian M., Ahmadpour S., Varasteh A.R., Haghir H. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Exp. Diab. Res. 2008, 2008:638467.
71. Jayatissa M.N., Bisgaard C.F., West M.J., Wiborg O. The number of granule cells in rat hippocampus is reduced after chronic mild stress and re-established after chronic escitalopram treatment. Neuropharmacology 2008, 54:530-541.
72. Jedrziewski M.K., Ewbank D.C., Wang H., Trojanowski J.Q. Exercise and cognition: results from the National Long Term Care Survey. Alzheimer's Dementia J. Alzheimer's Assoc. 2010, 6:448-455.
73. Jing X.H., Chen S.L., Shi H., Cai H., Jin Z.G. Electroacupuncture restores learning and memory impairment induced by both diabetes mellitus and cerebral ischemia in rats. Neurosci. Lett. 2008, 443:193-198.
74. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000, 43:500-506.
75. Kamal A., Biessels G.J., Ramakers G.M., Hendrik Gispen W. The effect of short duration streptozotocin-induced diabetes mellitus on the late phase and threshold of long-term potentiation induction in the rat. Brain Res. 2005, 1053:126-130.
76. Kang J.O., Kim S.K., Hong S.E., Lee T.H., Kim C.J. Low dose radiation overcomes diabetes-induced suppression of hippocampal neuronal cell proliferation in rats. J. Korean Med. Sci. 2006, 21:500-505.
77. Koehl M., Abrous D.N. A new chapter in the field of memory: adult hippocampal neurogenesis. Eur. J. Neurosci. 2011, 33:1101-1114.
78. Korczak D.J., Pereira S., Koulajian K., Matejcek A., Giacca A. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia 2011, 54:2483-2493.
79. Kuhad A., Bishnoi M., Tiwari V., Chopra K. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol. Biochem. Behav. 2009, 92:251-259.
80. Lang B.T., Yan Y., Dempsey R.J., Vemuganti R. Impaired neurogenesis in adult type-2 diabetic rats. Brain Res. 2009, 1258:25-33.
81. Lawrence J.M., Standiford D.A., Loots B., Klingensmith G.J., Williams D.E., Ruggiero A., Liese A.D., Bell R.A., Waitzfelder B.E., McKeown R.E. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 2006, 117:1348-1358.
82. Lazarov O., Mattson M.P., Peterson D.A., Pimplikar S.W., van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci. 2010, 33:569-579.
83. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
84. Leonard B.L., Watson R.N., Loomes K.M., Phillips A.R., Cooper G.J. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol. 2005, 42:162-170.
85. Leuner B., Gould E. Structural plasticity and hippocampal function. Annu. Rev. Psychol. 2010, 61(111-140):C111-C113.
86. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., Magarinos A.M., Allen P.B., Greengard P., Luine V., McEwen B.S. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2185-2190.
87. Li Z.G., Zhang W., Sima A.A. C-peptide prevents hippocampal apoptosis in type 1 diabetes. Int. J. Exp. Diabetes Res. 2002, 3:241-245.
88. Li Z.G., Zhang W., Sima A.A. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res. 2005, 1037:12-24.
89. Liang X.C., Guo S.S., Hagino N. Current status of clinical and experimental researches on cognitive impairment in diabetes. Chin. J. Integr. Med. 2006, 12:68-74.
90. Lindqvist A., Mohapel P., Bouter B., Frielingsdorf H., Pizzo D., Brundin P., Erlanson-Albertsson C. High-fat diet impairs hippocampal neurogenesis in male rats. Eur. J. Neurol. 2006, 13:1385-1388.
91. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144.
92. Lucki I. Depression: Animal models. Encyclopedia of Psychopharmacology 2010, 394-399. Springer-Verlag, Berlin. I.P. Stolerman (Ed.).
93. Luppi P., Cifarelli V., Wahren J. C-peptide and long-term complications of diabetes. Pediatric Diab. 2011, 12:276-292.
94. MacLullich A.M., Seckl J.R. Diabetes and cognitive decline: are steroids the missing link?. Cell Metab. 2008, 7:286-287.
95. Magarinos A.M., Jain K., Blount E.D., Reagan L., Smith B.H., McEwen B.S. Peritoneal implantation of macroencapsulated porcine pancreatic islets in diabetic rats ameliorates severe hyperglycemia and prevents retraction and simplification of hippocampal dendrites. Brain Res. 2001, 902:282-287.
96. Magarinos A.M., McEwen B.S. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11056-11061.
97. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. Off. J. Soc. Neurosci. 2000, 20:9104-9110.
98. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
99. Malone J.I., Hanna S., Saporta S., Mervis R.F., Park C.R., Chong L., Diamond D.M. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr. Diab. 2008, 9:531-539.
100. Manganas L.N., Zhang X., Li Y., Hazel R.D., Smith S.D., Wagshul M.E., Henn F., Benveniste H., Djuric P.M., Enikolopov G., Maletic-Savatic M. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 2007, 318:980-985.
101. Manschot S.M., Biessels G.J., Cameron N.E., Cotter M.A., Kamal A., Kappelle L.J., Gispen W.H. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res. 2003, 966:274-282.
102. Martinez-Tellez R., Gomez-Villalobos Mde J., Flores G. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res. 2005, 1048:108-115.
103. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet 2012, 379:2291-2299.
104. McDonnell M.N., Smith A.E., Mackintosh S.F. Aerobic exercise to improve cognitive function in adults with neurological disorders: a systematic review. Arch. Phys. Med. Rehab. 2011, 92:1044-1052.
105. McEwen B.S. Protective and damaging effects of stress mediators: central role of the brain. Dialog. Clin. Neurosci. 2006, 8:367-381.
106. McIntyre R.S., Kenna H.A., Nguyen H.T., Law C.W., Sultan F., Woldeyohannes H.O., Adams A.K., Cheng J.S., Lourenco M., Kennedy S.H., Rasgon N.L. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders?. Adv. Ther. 2010, 27:63-80.
107. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., Snoek F.J., Heine R.J. Diabetic encephalopathy: A concept in need of a definition. Diabetologia 2006, 49:1447-1448.
108. Musselman D.L., Betan E., Larsen H., Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 2003, 54:317-329.
109. NDIC National Diabetes Statistics 2011.
110. Neylan T.C., Mueller S.G., Wang Z., Metzler T.J., Lenoci M., Truran D., Marmar C.R., Weiner M.W., Schuff N. Insomnia severity is associated with a decreased volume of the CA3/dentate gyrus hippocampal subfield. Biol. Psychiatry 2010, 68:494-496.
111. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18:363-374.
112. Paradisi M., Fernandez M., Del Vecchio G., Lizzo G., Marucci G., Giulioni M., Pozzati E., Antonelli T., Lanzoni G., Bagnara G.P., Giardino L., Calza L. Ex vivo study of dentate gyrus neurogenesis in human pharmacoresistant temporal lobe epilepsy. Neuropathol. Appl. Neurobiol. 2010, 36:535-550.
113. Park H.R., Park M., Choi J., Park K.Y., Chung H.Y., Lee J. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci. Lett. 2010, 482:235-239.
114. Petrak F., Herpertz S. Treatment of depression in diabetes: an update. Curr. Opin. Psychiatry 2009, 22:211-217.
115. Piazza F.V., Pinto G.V., Trott G., Marcuzzo S., Gomez R., Fernandes Mda C. Enriched environment prevents memory deficits in type 1 diabetic rats. Behav. Brain Res. 2011, 217:16-20.
116. Pinnock S.B., Blake A.M., Platt N.J., Herbert J. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS One 2010, 5:e13652.
117. Pollak D.D., Rey C.E., Monje F.J. Rodent models in depression research: classical strategies and new directions. Ann. Med. 2010, 42:252-264.
118. Porter D.W., Irwin N., Flatt P.R., Holscher C., Gault V.A. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice. Eur. J. Pharmacol. 2011, 650:688-693.
119. Porter D.W., Kerr B.D., Flatt P.R., Holscher C., Gault V.A. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diab. Obesity Metab. 2010, 12:891-899.
120. Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diab. Metab. Res. Rev. 2005, 21:495-504.
121. Renn B.N., Feliciano L., Segal D.L. The bidirectional relationship of depression and diabetes: a systematic review. Clin. Psychol. Rev. 2011, 31:1239-1246.
122. Revsin Y., Rekers N.V., Louwe M.C., Saravia F.E., De Nicola A.F., de Kloet E.R., Oitzl M.S. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009, 34:747-758.
123. Rittenhouse P.A., Lopez-Rubalcava C., Stanwood G.D., Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology 2002, 27:303-318.
124. Rivera P., Romero-Zerbo Y., Pavon F.J., Serrano A., Lopez-Avalos M.D., Cifuentes M., Grondona J.M., Bermudez-Silva F.J., Fernandez-Llebrez P., de Fonseca F.R., Suarez J., Perez-Martin M. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions. Eur. J. Neurosci. 2011, 33:1577-1586.
125. Roy T., Lloyd C.E. Epidemiology of depression and diabetes: a systematic review. J. Affective Disorders 2012, 142(Suppl):S8-S21.
126. Saravia F., Beauquis J., Pietranera L., De Nicola A.F. Neuroprotective effects of estradiol in hippocampal neurons and glia of middle age mice. Psychoneuroendocrinology 2007, 32:480-492.
127. Saravia F.E., Beauquis J., Revsin Y., Homo-Delarche F., de Kloet E.R., De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell. Mol. Neurobiol. 2006, 26:943-957.
128. Saravia F., Revsin Y., Lux-Lantos V., Beauquis J., Homo-Delarche F., De Nicola A.F. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J. Neuroendocrinol. 2004, 16:704-710.
129. Schoenfeld T.J., Gould E. Stress, stress hormones, and adult neurogenesis. Exp. Neurol. 2012, 233:12-21.
130. Sharma A.N., Elased K.M., Garrett T.L., Lucot J.B. Neurobehavioral deficits in db/db diabetic mice. Physiol. Behav. 2010, 101:381-388.
131. Sharma S., Rakoczy S., Brown-Borg H. Assessment of spatial memory in mice. Life Sci. 2010, 87:521-536.
132. Shors T.J., Anderson M.L., Curlik D.M., Nokia M.S. Use it or lose it: how neurogenesis keeps the brain fit for learning. Behav. Brain Res. 2012, 227:450-458.
133. Silva N., Atlantis E., Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?. Curr. Psychiatry Rep. 2012, 14:8-14.
134. Sima A.A., Li Z.G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 2005, 54:1497-1505.
135. Sisti H.M., Glass A.L., Shors T.J. Neurogenesis and the spacing effect: learning over time enhances memory and the survival of new neurons. Learn Mem. 2007, 14:368-375.
136. Snyder J.S., Hong N.S., McDonald R.J., Wojtowicz J.M. A role for adult neurogenesis in spatial long-term memory. Neuroscience 2005, 130:843-852.
137. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
138. Sone M., Osamura R.Y. Leptin and the pituitary. Pituitary 2001, 4:15-23.
139. Song C., Wang H. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:760-768.
140. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 2008, 11:309-317.
141. Stranahan A.M., Arumugam T.V., Lee K., Mattson M.P. Mineralocorticoid receptor activation restores medial perforant path LTP in diabetic rats. Synapse 2010, 64:528-532.
142. Stranahan A.M., Lee K., Martin B., Maudsley S., Golden E., Cutler R.G., Mattson M.P. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
143. Stuart M.J., Baune B.T. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci. Biobehav. Rev. 2012, 36:658-676.
144. Tata D.A., Anderson B.J. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiol. Behav. 2010, 99:186-193.
145. Taupin P. Adult neurogenesis and neuroplasticity. Restor. Neurol. Neurosci. 2006, 24:9-15.
146. Trudeau F., Gagnon S., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur. J. Pharmacol. 2004, 490:177-186.
147. van Praag H. Neurogenesis and exercise: past and future directions. Neuromol. Med. 2008, 10:128-140.
148. Wang J., Gallagher D., Devito L.M., Cancino G.I., Tsui D., He L., Keller G.M., Frankland P.W., Kaplan D.R., Miller F.D. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell 2012, 11:23-35.
149. Wang S.H., Sun Z.L., Guo Y.J., Yuan Y., Yang B.Q. Diabetes impairs hippocampal function via advanced glycation end product mediated new neuron generation in animals with diabetes-related depression. Toxicol. Sci. 2009, 111:72-79.
150. Wang S.H., Zhang Z.J., Guo Y.J., Teng G.J., Chen B.A. Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression. Psychiatry Res. 2009, 170:245-251.
151. Wang Z., Neylan T.C., Mueller S.G., Lenoci M., Truran D., Marmar C.R., Weiner M.W., Schuff N. Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch. Gen. Psychiatry 2010, 67:296-303.
152. WHO Diabetes Programme Facts & Figures 2011.
153. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab. Care 2004, 27:1047-1053.
154. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
155. Yi S.S., Hwang I.K., Yoo K.Y., Park O.K., Yu J., Yan B., Kim I.Y., Kim Y.N., Pai T., Song W., Lee I.S., Won M.H., Seong J.K., Yoon Y.S. Effects of treadmill exercise on cell proliferation and differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes. Neurochem. Res. 2009, 34:1039-1046.
156. Zhang T., Jia W., Sun X. 3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol. Res. 2010, 32:390-396.
157. Zhang W.J., Tan Y.F., Yue J.T., Vranic M., Wojtowicz J.M. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol. Scand. 2008, 117:205-210.
158. Zoladz J.A., Pilc A. The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. J. Physiol. Pharmacol. 2010, 61:533-541.
159. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:722-729.